SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-008587
Filing Date
2015-11-13
Accepted
2015-11-13 16:33:42
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0915_dandritbiotech.htm 10-Q 383862
2 CERTIFICATION f10q0915ex31i_dandritbiotech.htm EX-31.1 8580
3 CERTIFICATION f10q0915ex31ii_dandritbiote.htm EX-31.2 9907
4 CERTIFICATION f10q0915ex32i_dandritbiotech.htm EX-32.1 6421
  Complete submission text file 0001213900-15-008587.txt   2648436

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ddrt-20150930.xsd EX-101.SCH 32319
6 XBRL INSTANCE FILE ddrt-20150930.xml EX-101.INS 405239
7 XBRL CALCULATION FILE ddrt-20150930_cal.xml EX-101.CAL 44686
8 XBRL DEFINITION FILE ddrt-20150930_def.xml EX-101.DEF 64850
9 XBRL LABEL FILE ddrt-20150930_lab.xml EX-101.LAB 298794
10 XBRL PRESENTATION FILE ddrt-20150930_pre.xml EX-101.PRE 181498
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 151229584
SIC: 2834 Pharmaceutical Preparations